A study published in the Journal of Clinical Oncology confirms that one of the first Food and Drug Administration-approved ...
Genetic risk models and variant classification tools are refining breast cancer risk assessment by identifying high-risk ...
Researchers at the University of Geneva, together with colleagues in Switzerland, France, the United States and Israel, ...
A cutting-edge therapy using base-edited immune cells is offering a major breakthrough for patients with one of the toughest ...
New Cancer Therapy Brings Remission For Patients With Deadly T-Cell Leukaemia. A small group of patients with an otherwise incurable form of T‐cell leukaemia have seen their cancer driven into ...
From rare diseases to chronic conditions, epigenetic editing unlocks new ways to control gene activity without altering the genetic code.
The FDA on Tuesday approved etuvetidigene autotemcel (Waskyra) as the first cell-based gene therapy for patients 6 months and ...
A new University of California San Diego School of Medicine study offers a unified biological model to explain how genetic ...
The three-hit model, developed from more than a decade of systems biology research, proposes that autism develops when three ...
Kids and teenagers with spinal muscular atrophy had more mobility after receiving a single-dose gene replacement therapy, ...
Kelonia Therapeutics' KLN-1010 has shown promising early results in a phase 1 trial for relapsed or refractory multiple ...
BBC Breakfast is broadcast every day at 6am on BBC One.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback